loader2
Login Open ICICI 3-in-1 Account

Dec 18, 2025

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 38.95 9.12 14.64 37.91 0.04 44.95 35.66
Cipla Ltd 22.25 4.39 3.67 17.28 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 39.12 7.17 7.39 27.93 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 18.50 3.25 2.95 13.06 0.11 23.05 18.53
Lupin Ltd 22.20 4.25 4.92 18.65 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 59.61 11.08 15.10 39.72 0.50 25.84 26.46
Ipca Laboratories Ltd 41.51 3.96 4.77 24.21 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 41.08 8.19 5.53 27.88 0.04 19.52 16.16
Aurobindo Pharma Ltd 20.26 2.18 1.98 11.42 0.24 14.16 11.15
Wockhardt Ltd -432.79 7.33 4.83 78.11 0.57 3.87 -1.48
Ajanta Pharma Ltd 33.35 6.99 7.53 25.33 0.01 31.98 25.02
Gland Pharma Ltd 34.48 4.85 2.85 18.11 0.00 15.83 11.62
Biocon Ltd 67.79 3.39 1.93 19.33 0.84 6.86 6.90
Alkem Laboratories Ltd 27.92 5.19 5.04 27.46 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 54.43 4.13 5.74 31.06 0.22 18.48 15.79
Zydus Lifesciences Ltd 18.37 3.98 3.65 12.73 0.09 24.56 21.08
Divis Laboratories Ltd 67.24 17.85 10.84 55.43 0.00 20.42 15.35
Mankind Pharma Ltd 49.11 7.14 5.70 32.54 0.37 16.04 14.83
Laurus Labs Ltd 79.90 9.81 11.35 55.68 0.62 8.80 7.36
Piramal Pharma Ltd -934.44 2.44 2.76 22.41 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 67830.25
(-0.3622%)
72262.90 56192.45
Nifty Bank 58912.85
(-0.0236%)
60114.30 47702.90
Nifty 50 25815.55
(-0.0116%)
26325.80 21743.65
Nifty 100 26324.65
(-0.0683%)
26859.50 22177.35
BSE SmallCap 50172.10
(-0.2807%)
57069.83 41013.68
BSE Sensex 84481.81
(-0.0921%)
86159.02 71425.01
BSE MidCap 45968.49
(0.0484%)
47891.64 37203.21
BSE 100 27007.0
(-0.0373%)
27539.85 22539.11

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

DCM Shriram Industries revises record date for scheme of arrangement

DCM Shriram Industries has revised the record date for deciding entitlement for allotment of shares in R...

Dec 18, 2025 14:11
SEBI overhauls mutual fund expense rules to boost transparency

India`s market regulator, the Securities and Exchange Board of India, on Wednesday (17 December 2025) rol...

Dec 18, 2025 10:17
A-1 revises record date for bonus issue and stock split

A-1 has revised the record date from 22 December 2025 to 31 December 2025 for purpose of determining shar...

Dec 15, 2025 18:54
Ajmera Realty & Infra India fixes record date for stock split

Ajmera Realty & Infra India has fixed 15 January 2026 as record date for the purpose of determining the e...

Dec 15, 2025 13:50
Krishival Foods fixes record date for rights issue

Krishival Foods has fixed 17 December 2025 as record date to determine the shareholders who will be eligi...

Dec 12, 2025 09:31
Sylph Technologies fixes record date for bonus issue

Sylph Technologies has fixed 17 December 2025 as record date for bonus issue. Cap...

Dec 12, 2025 09:27
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.